AGRX - Agile Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development14,42820,92925,62213,365
Selling General and Administrative12,3838,7927,4675,150
Non Recurring----
Others----
Total Operating Expenses26,81129,72133,08918,515
Operating Income or Loss-26,811-29,721-33,089-18,515
Income from Continuing Operations
Total Other Income/Expenses Net-1,493-2,095-3,218-1,215
Earnings Before Interest and Taxes-26,811-29,721-33,089-18,515
Interest Expense-1,918-2,446-2,077-1,566
Income Before Tax-28,304-31,816-36,307-19,730
Income Tax Expense--3,075-5,972-3,653
Minority Interest----
Net Income From Continuing Ops-28,304-28,741-30,335-16,077
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-28,304-28,741-30,335-16,077
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-28,304-28,741-30,335-16,077